479 third-party lab reports published Volume pricing on every peptide, applied automatically in the cart: 3% off 2–3 · 8% off 4–5 · 12% off 6–7 · 15% off 8–9 · 20% off 10–19 · 25% off 20–29 · 30% off 30–39 · 35% off 40+ units · solvents and lab supplies excluded 99.65% median purity across 272 lots 257 / 257 lots pass sterility

‹ Certificates GHK-Cu Capsules Lot GHK0022026-01

Lab report (Certificate of Analysis, COA)

GHK-Cu Capsules · GHK-Cu 2.56mg

Batch GHK0022026-01 · tested March 11, 2026 (238 days ago) · released May 28, 2026

All tests passed

Batch
#GHK0022026-01 6 tests
Mass
GHK-Cu 2.56mg
Issuing lab accreditation
Vanguard · ISO 17025:2017 / A2LA #6377.01.01

No tier shown — see the tests listed on the report

Conformity: Not assessable — every reported unit passed on all 3 test rows · QA approval corroborates: Vanguard Laboratory, Tori Johnson, 2026-03-11

Vanguard · issuing lab

Notes

Content audit 9 Sep 2026: lab id (blank) → V260218-22 003. Certificate prints: prints compound "GHK-Cu", lot "GHK0022026-01", lab id "V260218-22 003", content 2.56 mg

Reports for this lot

  1. Vanguard Laboratory this report · tested March 11, 2026 · 3 results · QA approvalVanguard · issuing labAll tests passed

Test by test

3 results on the report · 3 rows computed from the per-unit values · 1 ISO 17025:2017-accredited lab · each test used up to 1 vial from this lot (rows are not added together) · every row names the chapter or house rule it follows

–Purity consistency between unitsNot on this report
no purity result printed on this lab report
✓Net peptide content (assay)Within limits
2.56 mg · 1 unit · USP <621> (procedural chapter)
–Content consistency between unitsSingle measurement
1 unit printed (2.56 mg) · a between-unit spread needs two or more measured units
✓Heavy metalsWithin limits
4 elements non-detect · 1 unit · dose-scaled limits derived from USP <232> (limits chapter)

–Residual solventsNot on this lot's panel
not on this report · this batch was tested to our earlier standard; newer batches get all 15 tests
–TFA residualNot on this lot's panel
not on this report · this batch was tested to our earlier standard; newer batches get all 15 tests
–Container closureNot on this lot's panel
not on this report · this batch was tested to our earlier standard; newer batches get all 15 tests
–SolubilityNot on this lot's panel
not on this report · this batch was tested to our earlier standard; newer batches get all 15 tests
✓MicrobialWithin limits
90 CFU/g (TAC), <10 CFU/g (TYM) · 1 unit · no chapter named in the record; a screen
–ConformityNot assessable
every reported unit passed on all 3 test rows · QA approval corroborates: Vanguard Laboratory, Tori Johnson, 2026-03-11 · house check · agreement across all tests, unit to unit; QA approval corroborates

A chapter number names the method or limit a result follows; it does not describe the product. Chapters below 1000 are procedures or limits; 1000-series chapters are informational. USP <905> is the compendial test for between-unit uniformity: it assays 10 units, so a 3-unit certificate cannot yield its acceptance value — the content row is a house check with <905> named as the reference only.

Tested by Vanguard Laboratory · Released May 28, 2026

Permanent URL: https://peptidology.co/coa/ghk-cu-capsules-lot-ghk0022026-01/

For research use only. Not intended for diagnostic or therapeutic use.

This certificate has been viewed 11 times.